Medpace Holdings Inc
NASDAQ:MEDP
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
Medpace Holdings Inc
NASDAQ:MEDP
|
12.4B USD | 23.7 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 27.5 | ||
US |
Danaher Corp
NYSE:DHR
|
194.8B USD | 29.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
36.1B CHF | 26.7 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
39.9B USD | 22.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
38.8B USD | 20.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
52.4T KRW | 31.2 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
30.7B USD | 32.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.4B USD | 22.4 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
23B USD | 29.7 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
17B EUR | 30.4 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.